483 Cardinal Health 414 Feb 2020

483 Cardinal Health 414 Feb 2020

Kenneth Gee FDA, Anita Narula FDA$119.00 - Available Now

FDA investigators audited the Cardinal Health 414 - Seattle, WA, United States facility and issued inspectional observations (via FDA 483) on 25 Feb 2020.

Product details

  • Category: Human Drugs
  • Inspection end: 25 Feb 2020
  • Location: Seattle, United States
  • FEI: 3003706047
Add To Cart